These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21736678)

  • 1. Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis.
    Hatton N; Frech T; Smith B; Sawitzke A; Scholand MB; Markewitz B
    Int J Clin Pract Suppl; 2011 Aug; (172):35-43. PubMed ID: 21736678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH.
    Clements PJ; Tan M; McLaughlin VV; Oudiz RJ; Tapson VF; Channick RN; Rubin LJ; Langer A;
    Ann Rheum Dis; 2012 Feb; 71(2):249-52. PubMed ID: 21998119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.
    Broen JC; Bossini-Castillo L; van Bon L; Vonk MC; Knaapen H; Beretta L; Rueda B; Hesselstrand R; Herrick A; Worthington J; Hunzelman N; Denton CP; Fonseca C; Riemekasten G; Kiener HP; Scorza R; Simeón CP; Ortego-Centeno N; Gonzalez-Gay MA; Airò P; Coenen MJ; Martín J; Radstake TR;
    Arthritis Rheum; 2012 Jan; 64(1):264-71. PubMed ID: 21905008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired bone morphogenetic protein receptor II signaling in a transforming growth factor-β-dependent mouse model of pulmonary hypertension and in systemic sclerosis.
    Gilbane AJ; Derrett-Smith E; Trinder SL; Good RB; Pearce A; Denton CP; Holmes AM
    Am J Respir Crit Care Med; 2015 Mar; 191(6):665-77. PubMed ID: 25606692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association.
    Zhou X; Tan FK; Stivers DN; Arnett FC
    Arthritis Rheum; 2000 May; 43(5):1068-73. PubMed ID: 10817561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pulmonary hypertension: what did we learn from genes?
    Sztrymf B; Yaïci A; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S91-100. PubMed ID: 16457021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hypertension in systemic sclerosis.
    Chatterjee S
    Semin Arthritis Rheum; 2011 Aug; 41(1):19-37. PubMed ID: 21047671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGFβ receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients.
    Koumakis E; Wipff J; Dieudé P; Ruiz B; Bouaziz M; Revillod L; Guedj M; Distler JH; Matucci-Cerinic M; Humbert M; Riemekasten G; Airo P; Melchers I; Hachulla E; Cusi D; Wichmann HE; Hunzelmann N; Tiev K; Caramaschi P; Diot E; Kowal-Bielecka O; Cuomo G; Walker U; Czirják L; Damjanov N; Lupoli S; Conti C; Müller-Nurasyid M; Müller-Ladner U; Riccieri V; Cracowski JL; Cozzi F; Bournia VK; Vlachoyiannopoulos P; Chiocchia G; Boileau C; Allanore Y
    Ann Rheum Dis; 2012 Nov; 71(11):1900-3. PubMed ID: 22896741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.
    Pannu J; Gore-Hyer E; Yamanaka M; Smith EA; Rubinchik S; Dong JY; Jablonska S; Blaszczyk M; Trojanowska M
    Arthritis Rheum; 2004 May; 50(5):1566-77. PubMed ID: 15146427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis.
    Sugiura Y; Banno S; Matsumoto Y; Niimi T; Yoshinouchi T; Hayami Y; Naniwa T; Ueda R
    J Rheumatol; 2003 Jul; 30(7):1520-3. PubMed ID: 12858451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension.
    Derrett-Smith EC; Dooley A; Gilbane AJ; Trinder SL; Khan K; Baliga R; Holmes AM; Hobbs AJ; Abraham D; Denton CP
    Arthritis Rheum; 2013 Nov; 65(11):2928-39. PubMed ID: 23839959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of TGF-β or BMPR2 signaling pathway-related miRNA in pulmonary arterial hypertension and systemic sclerosis.
    Xu B; Xu G; Yu Y; Lin J
    Arthritis Res Ther; 2021 Nov; 23(1):288. PubMed ID: 34819148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.
    Vonk MC; Broers B; Heijdra YF; Ton E; Snijder R; van Dijk AP; van Laar JM; Bootsma H; van Hal PT; van den Hoogen FH; van Daele PL
    Ann Rheum Dis; 2009 Jun; 68(6):961-5. PubMed ID: 18511546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.
    Williams MH; Handler CE; Akram R; Smith CJ; Das C; Smee J; Nair D; Denton CP; Black CM; Coghlan JG
    Eur Heart J; 2006 Jun; 27(12):1485-94. PubMed ID: 16682379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
    Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.
    Hofstee HM; Vonk Noordegraaf A; Voskuyl AE; Dijkmans BA; Postmus PE; Smulders YM; Serné EH
    Ann Rheum Dis; 2009 Feb; 68(2):191-5. PubMed ID: 18375538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension complicating connective tissue diseases.
    Hassoun PM
    Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
    Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of pulmonary arterial hypertension in scleroderma.
    Plastiras SC; Karadimitrakis SP; Kampolis C; Moutsopoulos HM; Tzelepis GE
    Semin Arthritis Rheum; 2007 Jun; 36(6):392-6. PubMed ID: 17204309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.